Nanjing Kebai Biotechnology Co., Ltd. was established in 2013. It is a comprehensive company specializing in providing independent biological products, outsourcing services for life medicine research, and a large biological database. In the years of development, the company has integrated resources and carefully researched and developed products and databases such as "tumor cell bank", "STR identification and comparison information bank", "DNA/RNA standard library", "drug target cell library", "tracer cell library", "protein standard library", "gene expression and mutation database". At the same time, a series of experimental outsourcing service platforms such as molecular biology, protein engineering, virus packaging, antibody engineering, cell engineering, and drug research and development have been developed.

The company attaches great importance to research and development innovation. With our cell function modification technology, high-precision and flexible gene editing tool platform, we provide services including kinases, GPCR, Cell models for drug screening targeting various diseases such as tumor immunity, as well as hundreds of various forms of standard reference materials for gene diagnosis. We provide products and services for various drug research and genetic diagnosis institutions, supporting further understanding of gene functions of all species and gene drivers of human diseases, as well as the development of personalized molecules, cells, ATCC cells, and gene therapies.